Intended for healthcare professionals


Drug eluting stents remain a “major concern” in the longer term, finds study

BMJ 2009; 338 doi: (Published 22 January 2009) Cite this as: BMJ 2009;338:b253
  1. David Spurgeon
  1. 1Quebec

    A three year Canadian study of more than 6000 patients who had an angioplasty with either drug eluting or bare metal stents concludes that the medicated version, now used in 85% of procedures in the United States and in 40% or more elsewhere, could be associated with longer term adverse events (CMAJ 2009;180:167-74, doi:10.1503/cmaj.080050).

    An accompanying commentary, from Columbia University Medical Centre, New York, notes that “despite the large and favourable long-term data on the use of drug-eluting stents from randomised controlled trials, meta-analyses and observational studies, the long-term safety of drug-eluting stents, especially regarding late and very late stent thrombosis, …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription